Morgan Stanley
MS
$211.82
+0.37%
Morgan Stanley is a global financial services firm providing investment banking, wealth management, and asset management services across 42 countries. It is a market leader in wealth and asset management, with $9.3 trillion in client assets, and maintains a top-tier institutional securities franchise. The current investor narrative centers on the firm's successful pivot toward stable fee-based businesses, which has driven record revenue and earnings growth, while also facing scrutiny over valuation levels and the sustainability of its wealth management expansion in a volatile market environment.…
MS
Morgan Stanley
$211.82
Related headlines
MS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $236.62 and implied upside of +11.7% versus the current price.
Average Target
$236.62
0 analysts
Implied Upside
+11.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$184 - $262
Analyst target range
Morgan Stanley has coverage from 21 analysts, with a consensus recommendation leaning bullish, as evidenced by recent actions from UBS, B of A Securities, and Evercore ISI all maintaining Buy or Outperform ratings. The average target price is $236.62, implying an upside of 10.2% from the current price of $214.77. The target range spans from a low of $184.00 to a high of $262.00, with the high target suggesting potential for further multiple expansion and continued strong earnings growth, while the low target reflects concerns about market volatility and potential margin compression.
Drowning in data?
Find the real signal!
Bulls vs Bears: MS Investment Factors
Morgan Stanley presents a compelling growth story with accelerating revenue, strong earnings momentum, and a reasonable valuation on a PEG basis. However, the stock trades at a premium to peers and faces sector headwinds from potential downgrades and high market expectations. The bull case is currently stronger, supported by robust fundamental performance and analyst optimism, but the key tension is whether the market will continue to reward the stock's premium valuation as growth normalizes. If revenue growth sustains above 20%, the stock likely re-rates higher; if it decelerates sharply, multiple compression could offset earnings gains.
Bullish
- Revenue Growth Accelerating Sharply: Q2 2026 revenue surged 22.4% YoY to $34.47B, up from 6.3% growth in Q2 2025, driven by strong capital markets and wealth management. This acceleration is broad-based across segments, indicating sustainable momentum.
- Undervalued on PEG Ratio: With a PEG ratio of 0.60, the stock trades at a discount to its growth rate, suggesting the market is not fully pricing in future earnings growth. This implies potential for upward re-rating as growth persists.
- Strong Earnings Growth Expected: Forward PE of 15.75x implies ~9% earnings growth, but analysts estimate EPS of $16.34 for the next year, which would represent a 14% increase from trailing EPS of $14.32. This suggests the market may be underestimating earnings power.
- Analyst Targets Indicate Upside: The average analyst target of $236.62 implies 10.2% upside, with a high target of $262 suggesting 22% potential. Recent actions from UBS, B of A, and Evercore all maintain Buy/Outperform ratings, reflecting positive sentiment.
Bearish
- High Valuation vs. Peers: With a trailing PE of 17.17x and EV/EBITDA of 24.15x, MS trades at a premium to many large-cap banks (e.g., JPMorgan at ~13x). This leaves little room for error and could lead to multiple compression if growth slows.
- Elevated Debt Levels: Debt-to-equity ratio of 4.26x is high, reflecting the capital-intensive nature of the business. While common for banks, it increases sensitivity to credit market disruptions and interest rate spikes.
- Negative Free Cash Flow: TTM free cash flow is -$1.05B, indicating the firm is consuming cash despite strong earnings. This could constrain capital returns or signal aggressive reinvestment, which may not yield immediate returns.
- Potential Overextension Near Highs: The stock trades at 92.5% of its 52-week range and has pulled back 7.5% from its July high of $228.55. This suggests the stock may be overbought and vulnerable to profit-taking or consolidation.
MS Technical Analysis
Morgan Stanley's stock is in a strong uptrend, with a 1-year price change of +43.0%, significantly outperforming the S&P 500's +18.6% over the same period. The current price of $214.77 sits at 92.5% of its 52-week range (low of $145.66, high of $232.25), indicating the stock is near its highs, reflecting robust momentum but also potential overextension. The 6-month change of +29.0% underscores the sustained bullish trend, though the stock has pulled back about 7.5% from its July high of $228.55, suggesting some consolidation.
Beta
1.21
1.21x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$146-$232
Price range past year
Annual Return
+42.3%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | +0.3% | +1.0% |
| 3m | -3.0% | +1.1% |
| 6m | +32.2% | +13.8% |
| 1y | +42.3% | +19.5% |
| ytd | +16.4% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Morgan Stanley's revenue trajectory is strongly accelerating, with Q2 2026 revenue of $34.47 billion, up 22.4% year-over-year, and sequential growth from $33.15 billion in Q1 2026 and $28.86 billion in Q4 2025. The growth is broad-based, with Wealth Management contributing $8.43 billion, Institutional Securities $7.93 billion, and Investment Management $1.72 billion in the latest quarter. This marks a significant acceleration from the 6.3% YoY growth in Q2 2025, driven by robust capital markets activity and continued organic growth in wealth management.
Quarterly Revenue
$34.5B
2026-06
Revenue YoY Growth
+22.4%
YoY Comparison
Gross Margin
61.7%
Latest Quarter
Free Cash Flow
$-1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Given Morgan Stanley's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 17.17x, while the forward PE is 15.75x, implying the market expects earnings growth of about 9% over the next year. The PEG ratio of 0.60 suggests the stock is undervalued relative to its growth rate, indicating that the market may not be fully pricing in the company's earnings momentum.
PE
17.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are notable: the debt-to-equity ratio of 4.26x is high, and while common for banks, it amplifies exposure to credit market stress. Negative free cash flow of -$1.05B TTM indicates the firm is not generating excess cash after investments, which could limit dividend growth or buybacks. However, net income of $5.58B in Q2 2026 and a payout ratio of 39% suggest earnings are solid, but the reliance on capital markets revenue (Institutional Securities contributed $7.93B) introduces cyclicality that could hit earnings if trading volumes decline.